How do comorbidities affect the decision to prescribe ruxolitinib for vitiligo?

Featuring Seemal Desai, MD | Education Advisor |

Clinical Assistant Professor 
Department of Dermatology
University of Texas Southwestern Medical Center
Dallas, TX

| Published April 02, 2025

Loading...

Related CME

Related Media

Powered by Polaris TM
Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2025 dermsquared | All Rights Reserved